Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Desai

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2017
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4Andreas H Groll, Robert Townsend, Amit Desai, et al.
Chemsuschem|September 24, 2017
Non-Aqueous Primary Li-Air Flow Battery and Optimization of its Cathode through Experiment and ModelingByoungsu Kim, Kensuke Takechi, Sichao Ma, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Social Distancing and Isolation Strategies to Prevent and Control the Transmission of COVID-19 and Other Infectious Diseases in Care Homes for Older People: An International ReviewSarah Sims, Ruth Harris, Shereen Hussein, et al.
Future Microbiology|August 2, 2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal diseaseJing Zhang, Yingyuan Zhang, Depei Wu, et al.
Mycoses|December 28, 2020
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysisJing Zhang, Yingyuan Zhang, Depei Wu, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Clinical Pharmacology and Therapeutics|March 27, 2024
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium PerspectiveMohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two StudiesDomenico Umberto De Rose, Iliana Bersani, Maria Paola Ronchetti, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy AdultsRobert Townsend, Albert Dietz, Christine Hale, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2017
Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4Andreas H Groll, Robert Townsend, Amit Desai, et al.
Chemsuschem|September 24, 2017
Non-Aqueous Primary Li-Air Flow Battery and Optimization of its Cathode through Experiment and ModelingByoungsu Kim, Kensuke Takechi, Sichao Ma, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
International Journal of Environmental Research and Public Health|March 25, 2022
Social Distancing and Isolation Strategies to Prevent and Control the Transmission of COVID-19 and Other Infectious Diseases in Care Homes for Older People: An International ReviewSarah Sims, Ruth Harris, Shereen Hussein, et al.
Future Microbiology|August 2, 2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal diseaseJing Zhang, Yingyuan Zhang, Depei Wu, et al.
Mycoses|December 28, 2020
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysisJing Zhang, Yingyuan Zhang, Depei Wu, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Clinical Pharmacology and Therapeutics|March 27, 2024
Impact of COVID-19 on the Conduct and Design of Clinical Trials: IQ Consortium PerspectiveMohamed-Eslam F Mohamed, Sandhya Girish, Rita Humeniuk, et al.
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two StudiesDomenico Umberto De Rose, Iliana Bersani, Maria Paola Ronchetti, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy AdultsRobert Townsend, Albert Dietz, Christine Hale, et al.
Pageof 9